LXEO
#3174
Lexeo Therapeutics, Inc. - Common Stock
4.6 2 USD
-0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.65%
Changement Mensuel
-2.12%
Evolution sur 6 mois
-38.40%
Changement Annuel
+11.06%
Clôture Précédente
4.6 5
Open
4.6 2
Low
4.6 2
High
4.6 2
Volume
105
Financials
- Market Capitalization 362.77 M
- Employee 59
- Founded 2017
- CEO N/A
- Website www.lexeotx.com
- Headquarter New York, United States
- FIGI BBG00YB1C8M5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3138 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.02 USD | -0.74% | +3.88% | -1.95% | +35.35% | 379.17 M USD | ||
| 3142 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.70 USD | -0.84% | -2.69% | +6.82% | +46.42% | 376.13 M USD | ||
| 3196 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.85 USD | -2.50% | -8.59% | -0.51% | +5.79% | 351.79 M USD | ||
| 3199 |  GALT Galectin Therapeutics Inc. - Common Stock | 5.34 USD | +16.09% | +18.40% | +103.82% | +90.71% | 351.68 M USD |